Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9962359 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
US10668040 | HORIZON THERAP | Treatment of urea cycle disorders in neonates and infants |
Sep, 2030
(6 years from now) | |
US10183006 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
US10183005 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
US9561197 | HORIZON THERAP | Methods of therapeutic monitoring of phenylacetic acid prodrugs |
Sep, 2030
(6 years from now) | |
US10183003 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
US10183002 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
US10183004 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
US10045958 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
US8642012 | HORIZON THERAP | Methods of treatment using ammonia-scavenging drugs |
Sep, 2030
(6 years from now) | |
US10045959 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
US9999608 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Sep, 2030
(6 years from now) | |
US9254278 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Mar, 2032
(8 years from now) | |
US9095559 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Mar, 2032
(8 years from now) | |
US8404215 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging |
Mar, 2032
(8 years from now) | |
US9326966 | HORIZON THERAP | Methods of therapeutic monitoring of nitrogen scavenging drugs |
Mar, 2032
(8 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
Orphan Drug Exclusivity (ODE) | Apr 28, 2024 |
Market Authorisation Date: 01 February, 2013
Treatment: Treatment of a urea cycle disorder; Dosage adjustment of a nitrogen scavenging drug in the treatment of a urea cycle disorder
Dosage: LIQUID;ORAL